Reagenzien und Instrumente für die Immunologie Zellbiologie und Molekularbiologie
 
> L-Lactic acid-2-13C1 [740788-63-0]

L-Lactic acid-2-13C1 [740788-63-0]

Drucken Drucken
Melden Sie sich an

Katalog-Nummer HY-Y0479S3-1mg

Size : 1mg

Marke : MedChemExpress

Weitere Informationen anfordern

Contact local distributor :


Telefonnummer : +1 850 650 7790

L-Lactic acid-2-13C1 is the 13C-labeled L-Lactic acid (HY-Y0479). L-Lactic acid is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

L-Lactic acid-2-<sup>13</sup>C<sub>1</sub> Chemische Struktur

L-Lactic acid-2-13C1 Chemische Struktur

CAS. Nr. : 740788-63-0

This product is a controlled substance and not for sale in your territory.

Alle Antibiotic Isoform-spezifische Produkte anzeigen:

Alle Isoformen anzeigen
Aminoglycoside Glycopeptide Lipopeptide Macrolide Oxazolidinone Quinolone Tetracycline β-lactam
Beschreibung

L-Lactic acid-2-13C1 is the 13C-labeled L-Lactic acid (HY-Y0479). L-Lactic acid is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid[1].

In Vitro

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

L-Lactic acid-2-13C1 Related Antibodies
Molekulargewicht

91.07

Formel

C213CH6O3
CAS. Nr.

740788-63-0

SMILES

C[13C@@H](C(O)=O)O
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise

  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.  [Content Brief]

  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

L-Lactic acid-2-13C1 Related Classifications

  • Infection
  • Others Anti-infection Metabolic Enzyme/Protease
  • Isotope-Labeled Compounds Bacterial Endogenous Metabolite Antibiotic

  • Molaritätsrechner

  • Verdünnungsrechner

Die Formel zur Berechnung von Molaritäten

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)

Diese Gleichung wird häufig abgekürzt als: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

L-Lactic acid-2-13C1740788-63-0Isotope-Labeled CompoundsBacterialEndogenous MetaboliteAntibioticInhibitorinhibitorinhibit